CH655853A5 - Zusammensetzung und verfahren zur stabilisierung radioaktiv markierter verbindungen mittels thiocarbonylierter diaethylentriamine. - Google Patents

Zusammensetzung und verfahren zur stabilisierung radioaktiv markierter verbindungen mittels thiocarbonylierter diaethylentriamine. Download PDF

Info

Publication number
CH655853A5
CH655853A5 CH3825/83A CH382583A CH655853A5 CH 655853 A5 CH655853 A5 CH 655853A5 CH 3825/83 A CH3825/83 A CH 3825/83A CH 382583 A CH382583 A CH 382583A CH 655853 A5 CH655853 A5 CH 655853A5
Authority
CH
Switzerland
Prior art keywords
stabilizing agent
compound
composition according
radioactively labeled
methyl
Prior art date
Application number
CH3825/83A
Other languages
German (de)
English (en)
Inventor
Nathan R Tzodikov
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of CH655853A5 publication Critical patent/CH655853A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH3825/83A 1982-07-12 1983-07-12 Zusammensetzung und verfahren zur stabilisierung radioaktiv markierter verbindungen mittels thiocarbonylierter diaethylentriamine. CH655853A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/397,501 US4411881A (en) 1982-07-12 1982-07-12 Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines

Publications (1)

Publication Number Publication Date
CH655853A5 true CH655853A5 (de) 1986-05-30

Family

ID=23571454

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3825/83A CH655853A5 (de) 1982-07-12 1983-07-12 Zusammensetzung und verfahren zur stabilisierung radioaktiv markierter verbindungen mittels thiocarbonylierter diaethylentriamine.

Country Status (7)

Country Link
US (1) US4411881A (enExample)
JP (1) JPS5924257A (enExample)
CA (1) CA1205070A (enExample)
CH (1) CH655853A5 (enExample)
DE (1) DE3324593C2 (enExample)
FR (1) FR2536998B1 (enExample)
GB (1) GB2123412B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
JPH0317229U (enExample) * 1989-06-30 1991-02-20
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
AU9172191A (en) * 1990-12-12 1992-07-08 Mallinckrodt Medical, Inc. Method of radioactive labelling of blood cells and kit therefor
WO1993002652A2 (en) * 1991-08-01 1993-02-18 Hybritech Incorporated Modified haptens useful as imaging and therapeutic agents
US5686058A (en) * 1992-04-30 1997-11-11 Amersham International Plc Radiolabelled nucleotide formulations stored in an unfrozen state
CA2105402C (en) * 1992-04-30 2000-04-04 Roger M. Price Radiolabelled compound formulations
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
RU2104035C1 (ru) * 1995-02-27 1998-02-10 Физико-энергетический институт Препарат, содержащий органическое соединение, меченное бета-радионуклидом
WO1997001520A1 (en) * 1995-06-28 1997-01-16 E.I. Du Pont De Nemours And Company Composition and method for stabilizing radiolabeled organic compounds
ATE314097T1 (de) 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
HUP0101921A2 (hu) * 2001-05-10 2004-01-28 Izotóp Intézet Kft Radioaktívan jelzett nukleotido/ka/t tartalmazó preparátumok és eljárás azok előállítására
JP5139678B2 (ja) * 2003-07-24 2013-02-06 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法
US11474106B2 (en) 2015-07-08 2022-10-18 Lawrence Livermore National Security, Llc Methods for cytotoxic chemotherapy-based predictive assays
WO2018132766A1 (en) * 2017-01-12 2018-07-19 The Regents Of The University Of California Cytotoxic chemotherapy-based predictive assays for acute myeloid leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919095A (en) * 1973-07-30 1975-11-11 Mobil Oil Corp Organic compositions containing antioxidant and antiwear additives
US3876550A (en) * 1974-04-15 1975-04-08 Lubrizol Corp Lubricant compositions
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds

Also Published As

Publication number Publication date
US4411881A (en) 1983-10-25
JPH0211105B2 (enExample) 1990-03-12
DE3324593C2 (de) 1986-10-23
FR2536998B1 (fr) 1988-01-22
GB2123412A (en) 1984-02-01
GB8316714D0 (en) 1983-07-20
DE3324593A1 (de) 1984-02-02
CA1205070A (en) 1986-05-27
JPS5924257A (ja) 1984-02-07
FR2536998A1 (fr) 1984-06-08
GB2123412B (en) 1986-03-05

Similar Documents

Publication Publication Date Title
CH655853A5 (de) Zusammensetzung und verfahren zur stabilisierung radioaktiv markierter verbindungen mittels thiocarbonylierter diaethylentriamine.
US20200222562A1 (en) Stabilization of radiopharmaceutical compositions using ascorbic acid
DE3032781A1 (de) Verfahren zur selektiven ablagerung einer radiopharmazeutischen verbindung in einem zielgewebe oder -organ und verbindungen zur durchfuehrung des verfahrens
CA1198365A (en) Method composition and kit for stabilizing radiolabeled compounds
DE69130182T2 (de) Methode und reagentien um technetium-99m-komplexe herzustellen
EP0108253A1 (de) Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung
EP0313712B1 (de) Stabile radiodiagnostische Präparate und ihre Herstellung
DE2639849C2 (de) Stabile Präparate wasserlöslicher Salze von Dehydroepiandrosteronsulfat zur parenteralen Verabreichung
DE69718406T2 (de) Strahlungsschutzmittel geignet zur Verwendung mit Radiopharmazeutika enthaltend reduzierbare aktive Inhaltsstoffe
DE2617895C3 (de) Dispersion zur Herstellung eines injizierbaren radiopharmazeutischen Scanning-Mittels
DE69532965T2 (de) Gegebenenfalls durch tc oder re radioaktiv markierte n3s2-chelate, geeignet für diagnostische oder therapeutische anwendungen
DE60206599T2 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
DE2458710A1 (de) Verfahren zur bestimmung von folat- verbindungen durch saettigungsanalyse
US4431626A (en) Tc-99m Labeled carrier for imaging
US5738836A (en) Composition for stabilizing radiolabeled organic compounds
DE19860289A1 (de) Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
DE69811680T2 (de) Stabile radioaktive medikamente
US5604112A (en) Method for detecting the cardiotoxicity of compounds
EP0012967A2 (de) (2,4,5-Trimethylacetanilido)-imino-diacetat, Technetium-99m-markiertes (2,4,5-Trimethylacetanilido)-iminodiacetat zur Leberfunktionsdiagnostik und Verfahren zu deren Herstellung
DE2551480B2 (de) Technetium-99m-markiertes Nierendiagnostikum und Verfahren zu seiner Herstellung
EP0019790B1 (de) Technetium-99m-markierte Acetanilidoiminodiacetate zur Leberfunktionsdiagnostik und Verfahren zu ihrer Herstellung
Dratz et al. An exploratory study of fe59-labeled ferrocene as a carrier in tracer techniques
DE19632052C2 (de) Benzamidderivate und deren Verwendung zur Diagnose und Behandlung von Tumoren, insbesondere Melanomen
SU1051064A1 (ru) Натриевые соли @ -( @ -йодбензоиламино)-алифатических карбоновых кислот,меченных радиоизотопами йода,в качестве радиоактивных средств изучени процессов окислени жирных кислот в организме
Jedinakova Method of lanthanide separation from strongly acid aqueous solutions

Legal Events

Date Code Title Description
PUE Assignment

Owner name: E.I. DU PONT DE NEMOURS & COMPANY TRANSFER- NEN LI

PL Patent ceased